Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.44 |
| ▸ | GRM5 | P41594 | 4/20 | 0.44 |
| ▸ | CLK1 | P49759 | 1/20 | 0.44 |
| ▸ | CLK2 | P49760 | 1/20 | 0.44 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.44 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.44 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.44 |
| ▸ | CSF1R | P07333 | 4/20 | 0.43 |
| ▸ | EGFR | P00533 | 3/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13367575 | 0.87 | KCNA5 (0.41) | GRM5SMN1; SMN2KDM4EALDH1A1CYP2A6 | |
| SCHEMBL3409401 | 0.84 | KCNA5 (0.49) | GRM5ALDH1A1CYP2A6KCNA5 | |
| Hydrochloric Acid SCHEMBL4024971 | 0.82 | KCNA5 (0.47) | GRM5ALDH1A1CYP2A6KCNA5 | |
| SCHEMBL1697445 | 0.82 | ACHE (0.55) | CSF1REGFRSMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL12947815 | 0.81 | RAB9A (0.45) | KDM4CGRM5ALDH1A1CYP2A6TSHR | |
| SCHEMBL13367477 | 0.81 | KDM4C (0.46) | KDM4CCLK1CLK2DYRK1ACLK4 | |
| SCHEMBL12412921 | 0.81 | MEN1 (0.51) | GRM5EGFRKCNA5 | |
| SCHEMBL6732495 | 0.81 | ALDH1A1 (0.53) | GRM5KDM4EALDH1A1TSHRKCNA5 | |
| SCHEMBL23079716 | 0.79 | CYP19A1 (0.45) | GRM5CLK4ALDH1A1CYP2A6TSHR | |
| SCHEMBL5075470 | 0.79 | KCNA5 (0.50) | GRM5ALDH1A1CYP2A6KCNA5MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100108997-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OR10J3, OCIAD1, OCIAD2 | KDM4C 3304/4885GRM5 1277/4885CLK1 3170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.